Serum creatinine level and ESR values associated to clinical pathology types and prognosis of patients with renal injury caused by ANCA-associated vasculitis

The correlation between serum creatinine and erythrocyte sedimentation rate (ESR) values and clinical pathology and prognosis in patients with renal injury caused by anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis were analyzed. Eighty-six patients with ANCA-associated vasculitis (AAV) treated in the Affiliated Hospital of Qingdao University were enrolled in the study. Patients were assigned into an elderly group (n=45) or a non-elderly group (n=41) according to age. The serum creatinine (Scr) level was measured via the sarcosine oxidase method, and the erythrocyte sedimentation rate (ESR) was measured using the full-automatic ESR analyzer; the relationship between Scr and ESR values and the pathology type of patients was statistically analyzed. The mean levels of Scr and ESR in the 86 patients were 406.87±12.37 µmol/l and 83.83±7.64 mm/1 h, respectively. Importantly, the levels of Scr and the ESR in the elderly group were significantly higher than those in the non-elderly group (P<0.05). In addition, patients with high levels of Scr and accelerated ESR presented mainly the crescentic and sclerotic pathological types, while in the same patients the numbers of focal and mixed types were lower (P<0.05). Kaplan-Meier analysis showed that the survival rate in the elderly group was significantly lower than that in the non-elderly group, and likewise patients with high levels of Scr and accelerated ESR had significantly lower survival rates than those with low levels of Scr and normal ESR (P<0.05). The AUC of the Scr level was 0.901, the sensitivity 90.2%, the specificity 89.5% and the cut-off value was 392.5 µmol/l; while the AUC of the ESR level was 0.864, the sensitivity 89.2%, the specificity 88.5% and the cut-off value 72.8 mm/1 h. Logistic regression analysis showed that the levels of Scr (OR=2.315, P<0.01) and ESR (OR=1.847, P<0.01) were independent factors affecting the prognosis of patients. Based on our findings, the seric Scr level and the ESR are closely related to the clinicopathological features of the disease in patients with renal injury caused by ANCA-associated vasculitis, and they can be used as prognosis and treatment evaluation markers.

[1]  C. Pusey,et al.  The Histopathological Classification of ANCA-associated Glomerulonephritis Comes of Age , 2017, The Journal of Rheumatology.

[2]  M. Ge,et al.  [Geographical distribution of the Serum creatinine reference values of healthy adults]. , 2016, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[3]  S. El-Sayegh,et al.  Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis , 2015, BioMed research international.

[4]  W. van Biesen,et al.  Prognostic robustness of serum creatinine based AKI definitions in patients with sepsis: a prospective cohort study , 2015, BMC Nephrology.

[5]  A. Hanssen,et al.  Seronegative infections in hip and knee arthroplasty: periprosthetic infections with normal erythrocyte sedimentation rate and C-reactive protein level. , 2015, The bone & joint journal.

[6]  L. Wang,et al.  Neutrophil extracellular trap formation is associated with autophagy‐related signalling in ANCA‐associated vasculitis , 2015, Clinical and experimental immunology.

[7]  E. Giovannucci,et al.  Adolescent body mass index and erythrocyte sedimentation rate in relation to colorectal cancer risk , 2015, Gut.

[8]  A. Sanyal,et al.  P0198 : Percentage change in serum creatinine (SCr) is a sensitive indicator of therapeutic response to terlipressin in hepatorenal syndrome type 1 (HRS-1) , 2015 .

[9]  H. Sung,et al.  Clinical significance of prognosis using the neutrophil–lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma , 2015, BJU international.

[10]  P. van Paassen,et al.  Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial. , 2015, Annals of the rheumatic diseases.

[11]  K. Konstantinov,et al.  Infections and antineutrophil cytoplasmic antibodies: triggering mechanisms. , 2015, Autoimmunity reviews.

[12]  N. Chen,et al.  Clinical and Pathological Study on Patients With Primary Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis With Renal Immune Complex Deposition , 2015, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[13]  Masahiro Ito,et al.  Successful Management of Lupus Nephritis with High Titers of Myeloperoxidase Anti-Neutrophil Cytoplasmic Antibodies Using Tacrolimus. , 2015, Internal medicine.

[14]  M. Solé,et al.  ANCA serotype and histopathological classification for the prediction of renal outcome in ANCA-associated glomerulonephritis. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  A. Salama,et al.  Induction treatment of ANCA-associated vasculitis with a single dose of rituximab. , 2014, Rheumatology.

[16]  V. Jha,et al.  Histopathological classification of pauci-immune glomerulonephritis and its impact on outcome , 2014, Rheumatology International.

[17]  P. Höglund,et al.  Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear. , 2013, Kidney international.

[18]  A. Salama,et al.  Induction treatment of ANCA associated vasculitis with a single dose of rituximab , 2013 .

[19]  P. Paassen,et al.  Estimating renal survival using the ANCA-associated glomerulonephritis classification: A validation study , 2013 .

[20]  I. Bajema,et al.  L21. Kidneys in ANCA-associated vasculitis: what to learn from biopsies? , 2013, Presse medicale.

[21]  S. Wieczorek,et al.  The future of ANCA-associated vasculitis. , 2010, Rheumatic diseases clinics of North America.

[22]  C. Pusey,et al.  The Histopathological Classification of ANCA-associated Glomerulonephritis Comes of Age , 2017, The Journal of Rheumatology.

[23]  M. Ge,et al.  [Geographical distribution of the Serum creatinine reference values of healthy adults]. , 2016, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[24]  S. El-Sayegh,et al.  Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis , 2015, BioMed research international.

[25]  W. van Biesen,et al.  Prognostic robustness of serum creatinine based AKI definitions in patients with sepsis: a prospective cohort study , 2015, BMC Nephrology.

[26]  A. Hanssen,et al.  Seronegative infections in hip and knee arthroplasty: periprosthetic infections with normal erythrocyte sedimentation rate and C-reactive protein level. , 2015, The bone & joint journal.

[27]  L. Wang,et al.  Neutrophil extracellular trap formation is associated with autophagy‐related signalling in ANCA‐associated vasculitis , 2015, Clinical and experimental immunology.

[28]  E. Giovannucci,et al.  Adolescent body mass index and erythrocyte sedimentation rate in relation to colorectal cancer risk , 2015, Gut.

[29]  A. Sanyal,et al.  P0198 : Percentage change in serum creatinine (SCr) is a sensitive indicator of therapeutic response to terlipressin in hepatorenal syndrome type 1 (HRS-1) , 2015 .

[30]  H. Sung,et al.  Clinical significance of prognosis using the neutrophil–lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma , 2015, BJU international.

[31]  P. van Paassen,et al.  Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial. , 2015, Annals of the rheumatic diseases.

[32]  K. Konstantinov,et al.  Infections and antineutrophil cytoplasmic antibodies: triggering mechanisms. , 2015, Autoimmunity reviews.

[33]  N. Chen,et al.  Clinical and Pathological Study on Patients With Primary Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis With Renal Immune Complex Deposition , 2015, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[34]  Masahiro Ito,et al.  Successful Management of Lupus Nephritis with High Titers of Myeloperoxidase Anti-Neutrophil Cytoplasmic Antibodies Using Tacrolimus. , 2015, Internal medicine.

[35]  M. Solé,et al.  ANCA serotype and histopathological classification for the prediction of renal outcome in ANCA-associated glomerulonephritis. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[36]  A. Salama,et al.  Induction treatment of ANCA-associated vasculitis with a single dose of rituximab. , 2014, Rheumatology.

[37]  V. Jha,et al.  Histopathological classification of pauci-immune glomerulonephritis and its impact on outcome , 2014, Rheumatology International.

[38]  P. Höglund,et al.  Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear. , 2013, Kidney international.

[39]  A. Salama,et al.  Induction treatment of ANCA associated vasculitis with a single dose of rituximab , 2013 .

[40]  P. Paassen,et al.  Estimating renal survival using the ANCA-associated glomerulonephritis classification: A validation study , 2013 .

[41]  I. Bajema,et al.  L21. Kidneys in ANCA-associated vasculitis: what to learn from biopsies? , 2013, Presse medicale.